Meneldor Nieuws – Meneldor

Atriva announces closing of € 8.6 million ($ 10.2 million) oversubscribed convertible loan

Publication in PNAS unveils molecular pathway required for influenza virus replication with large potential as an antiviral drug target

Aptamer Group on BBC Look North 17th June 2020

LightOx May 2020

Atriva Therapeutics to Develop ATR-002 for Treatment of Patients with COVID-19 in Phase II Study

Therapieansätze gegen das Wuhan-Virus Deutsche Forscher entwickeln Impfstoffe gegen Coronaviren

Atriva Therapeutics to take part in three major conferences in San Francisco, USA, in the upcoming week

Xenikos receives FDA Fast Track designation for T-Guard(R) for treating steroid-refractory acute graft-versus-host disease

Britten kopen farmabedrijf Synthon uit Nijmegen

Dringend gezocht: nieuwe antibiotica

FOR MORE INFORMATION PLEASE CONTACT US